La reforma de cuidado de salud de la India brinda prósperas oportunidades del mercado farmacéutico.
25 de agosto de 2020
Global Pharma Insights habló con Deepak Sapra (a continuación), Director Ejecutivo de Ingredientes Farmacéuticos Activos en Dr. Reddy's Laboratories sobre su perspectiva acerca del estado actual del cuidado de salud y el sector de farmacéuticos de India y cómo está brindando oportunidades para fabricantes de fármacos domésticos y multinacionales, y profesionales de la salud a pesar de los desafíos de la actual pandemia del Coronavirus.
Para leer la entrevista haga clic aquí
+91 4049002253 Descargo de responsabilidad
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.